NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|1546926085|ref|WP_126927206|]
View 

oleate hydratase, partial [Staphylococcus epidermidis]

Protein Classification

oleate hydratase( domain architecture ID 10014518)

oleate hydratase is a FAD-containing double bond hydratase that catalyzes the hydration of oleate at its cis-9-double bond to form 10-hydroxyoctadecanoate

CATH:  3.50.50.60
PubMed:  19465645

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
PRK13977 PRK13977
myosin-cross-reactive antigen; Provisional
1-584 0e+00

myosin-cross-reactive antigen; Provisional


:

Pssm-ID: 237575  Cd Length: 576  Bit Score: 1091.40  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085   1 YEAFARPKKPENVDSKSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHF 80
Cdd:PRK13977    8 YEAFARPRKPEGVDNKKAYIIGSGLASLAAAVFLIRDGQMPGENITILEELDVPGGSLDGAGNPEKGYVARGGREMENHF 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  81 ECLWDLFRSIPSLEQPDASVLDEFYWLNKEDPNYSKCRAINSGGKRIDTDgDFTLSKKAIKEILSLCMKKEEDLEDVKIS 160
Cdd:PRK13977   88 ECLWDLFRSIPSLEDPGASVLDEFYWFNKDDPNYSKARLIHKRGEILDTD-KFGLSKKDRKELLKLLLTPEEKLDDKTIE 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 161 EVFTEDFLNSNFWLYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYG 240
Cdd:PRK13977  167 DWFSPEFFETNFWYYWRTMFAFEKWHSALEMRRYMHRFIHHIGGLPDLSGLKFTKYNQYESLVLPLIKYLEDHGVDFQYG 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 241 VQVDNILVDSTSSTKIAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAPPTKALGGSWTLWKNLANQSP 320
Cdd:PRK13977  247 TKVTDIDFDITGGKKTATAIHLTRNGKEETIDLTEDDLVFVTNGSITESSTYGDMDTPAPLNRELGGSWTLWKNIAAQSP 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 321 EFGRPEKFCDHIPDKSWlVSATTTTNNKKVISYIEKLSKRDVLSGRTVTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQV 400
Cdd:PRK13977  327 EFGNPDKFCGDIPESNW-ESFTVTTKDPKILPYIERITGRDPGSGKTVTGGIVTFKDSNWLMSITVNRQPHFKNQPKNET 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 401 SVWIYALYSDVKGDFIKKPITECTGSEICQEWLYHMGVPQEEIVELAQSECNTIPVYMPYVTAYFMPRAYKDRPLVVPNG 480
Cdd:PRK13977  406 VVWGYGLYPDRPGNYVKKPMRECTGEEILQELLYHLGVPEDKIEELAADSANTIPVMMPYITSQFMPRAKGDRPLVVPEG 485
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 481 SKNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLEVDRGVPEVYASEFDARVLIDAYYQLNDRKSLPelvnnnflkrs 560
Cdd:PRK13977  486 STNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYKLNDGKLLL----------- 554
                         570       580
                  ....*....|....*....|....
gi 1546926085 561 vlKNAMKKIQGTFIEELLRKHKLL 584
Cdd:PRK13977  555 --KEGLKKIKGTYIEELLKEYGLI 576
 
Name Accession Description Interval E-value
PRK13977 PRK13977
myosin-cross-reactive antigen; Provisional
1-584 0e+00

myosin-cross-reactive antigen; Provisional


Pssm-ID: 237575  Cd Length: 576  Bit Score: 1091.40  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085   1 YEAFARPKKPENVDSKSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHF 80
Cdd:PRK13977    8 YEAFARPRKPEGVDNKKAYIIGSGLASLAAAVFLIRDGQMPGENITILEELDVPGGSLDGAGNPEKGYVARGGREMENHF 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  81 ECLWDLFRSIPSLEQPDASVLDEFYWLNKEDPNYSKCRAINSGGKRIDTDgDFTLSKKAIKEILSLCMKKEEDLEDVKIS 160
Cdd:PRK13977   88 ECLWDLFRSIPSLEDPGASVLDEFYWFNKDDPNYSKARLIHKRGEILDTD-KFGLSKKDRKELLKLLLTPEEKLDDKTIE 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 161 EVFTEDFLNSNFWLYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYG 240
Cdd:PRK13977  167 DWFSPEFFETNFWYYWRTMFAFEKWHSALEMRRYMHRFIHHIGGLPDLSGLKFTKYNQYESLVLPLIKYLEDHGVDFQYG 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 241 VQVDNILVDSTSSTKIAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAPPTKALGGSWTLWKNLANQSP 320
Cdd:PRK13977  247 TKVTDIDFDITGGKKTATAIHLTRNGKEETIDLTEDDLVFVTNGSITESSTYGDMDTPAPLNRELGGSWTLWKNIAAQSP 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 321 EFGRPEKFCDHIPDKSWlVSATTTTNNKKVISYIEKLSKRDVLSGRTVTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQV 400
Cdd:PRK13977  327 EFGNPDKFCGDIPESNW-ESFTVTTKDPKILPYIERITGRDPGSGKTVTGGIVTFKDSNWLMSITVNRQPHFKNQPKNET 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 401 SVWIYALYSDVKGDFIKKPITECTGSEICQEWLYHMGVPQEEIVELAQSECNTIPVYMPYVTAYFMPRAYKDRPLVVPNG 480
Cdd:PRK13977  406 VVWGYGLYPDRPGNYVKKPMRECTGEEILQELLYHLGVPEDKIEELAADSANTIPVMMPYITSQFMPRAKGDRPLVVPEG 485
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 481 SKNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLEVDRGVPEVYASEFDARVLIDAYYQLNDRKSLPelvnnnflkrs 560
Cdd:PRK13977  486 STNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYKLNDGKLLL----------- 554
                         570       580
                  ....*....|....*....|....
gi 1546926085 561 vlKNAMKKIQGTFIEELLRKHKLL 584
Cdd:PRK13977  555 --KEGLKKIKGTYIEELLKEYGLI 576
COG4716 COG4716
Myosin-crossreactive antigen (function unknown) [Function unknown];
1-584 0e+00

Myosin-crossreactive antigen (function unknown) [Function unknown];


Pssm-ID: 443751  Cd Length: 578  Bit Score: 1087.56  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085   1 YEAFARPKKPENVDSKSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHF 80
Cdd:COG4716     8 YEAFARPRKPEGVDDKSAYLVGSGLASLAAAAFLIRDGQMPGENIHILEELDLPGGSLDGAGDPEKGYVIRGGREMENHF 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  81 ECLWDLFRSIPSLEQPDASVLDEFYWLNKEDPNYSKCRAINSGGKrIDTDGDFTLSKKAIKEILSLCMKKEEDLEDVKIS 160
Cdd:COG4716    88 ECLWDLFRSIPSLEDPGASVLDEFYWLNKDDPNYSKARLIHNQGE-ILDDGKFGLSKKARLEILKLFLTPEEDLDDKTIE 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 161 EVFTEDFLNSNFWLYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYG 240
Cdd:COG4716   167 DVFSEEFFESNFWLYWRTMFAFENWHSALEMKRYLHRFIHHIGGLPDLSALKFTKYNQYDSLVLPLVRWLKDHGVDFQYG 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 241 VQVDNILVDSTSSTKIAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAP-PTKALGGSWTLWKNLANQS 319
Cdd:COG4716   247 TKVTDVDFDISGGKKTATAIHLERDGKEETIDLTENDLVFVTNGSMTESSTYGDMDTPAPlNTDGPGGSWELWKNIAAKD 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 320 PEFGRPEKFCDHIPDKSWlVSATTTTNNKKVISYIEKLSKRDVLSGRTVTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQ 399
Cdd:COG4716   327 PEFGRPEKFCGNIEESNW-ESATVTTLDDKILPYIEKITGRDPYSGKVVTGGIVTFKDSNWLLSWTVNRQPHFKNQPDDV 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 400 VSVWIYALYSDVKGDFIKKPITECTGSEICQEWLYHMGVPqEEIVELAQSECNTIPVYMPYVTAYFMPRAYKDRPLVVPN 479
Cdd:COG4716   406 LVVWGYGLFSDKPGNYVKKPMRECTGEEILTELLYHLGVP-DQIEELAANSANTIPCMMPYITAQFMPRAAGDRPLVVPE 484
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 480 GSKNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLEVDRGVPEVYASEFDARVLIDAYYQLNDRKSLPElvnnnflkr 559
Cdd:COG4716   485 GSVNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYALNDGKKLPG--------- 555
                         570       580
                  ....*....|....*....|....*
gi 1546926085 560 svLKNAMKKIQGTFIEELLRKHKLL 584
Cdd:COG4716   556 --EGLLLKKLKGTYIEELLKEYKLI 578
MCRA pfam06100
MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have ...
16-513 0e+00

MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have structural features in common with the beta chain of the class II antigens, as well as myosin, and may play an important role in the pathogenesis. More recent work shows that these proteins act as hydratase enzymes that convert linoleic acid and oleic acid to their respective 10-hydroxy derivatives. It has been suggested that MCRA proteins catalyze the first step in conjugated linoleic acid production. Proteins in this family act in an FAD dependent manner. The structure of a fatty acid double-bond hydratase from Lactobacillus acidophilus has been recently solved showing four structural domains.


Pssm-ID: 428767  Cd Length: 492  Bit Score: 899.53  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  16 KSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHFECLWDLFRSIPSLEQ 95
Cdd:pfam06100   1 KKAYIVGSGIASLAAAVFLIRDAQMPGENIHILEELDVAGGSLDGAGDPEKGYVIRGGREMEFHYECLWDLLSSIPSLED 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  96 PDASVLDEFYWLNKEDPNYSKCRAINSGGKRIDTDGDFTLSKKAIKEILSLCMKKEEDLEDVKISEVFTEDFLNSNFWLY 175
Cdd:pfam06100  81 PGASVLDEIYWFNKRDPNYSKTRLIDNRGLEIVDDSKLGLSKKDRLELIKLFLTPEEELGDKRIEDVFSPSFFETNFWLM 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 176 WKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYGVQVDNILVDSTSSTK 255
Cdd:pfam06100 161 WSTMFAFQPWHSAVEFRRYLHRFIHEIPGLNDLSGLDRTKYNQYESIILPLVKYLKDQGVDFRFNTKVTDIDFDPTGDKK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 256 IAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAPP-TKALGGSWTLWKNLANQSPEFGRPEKFCDHIPD 334
Cdd:pfam06100 241 TVTGIHLTQDGEEETIDLGPDDLVFVTNGSMTEGSSYGDNDTPPPLnTDELGGSWSLWKKLAAKSPDFGNPEKFCTDIPE 320
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 335 KSWlVSATTTTNNKKVISYIEKLSKRDVLsgrtvTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQVSVWIYALYSDVKGD 414
Cdd:pfam06100 321 SKW-ESFTVTTKDPKFFDYIEKLTGNDPG-----TGGLVTFKDSNWLLSITVPRQPHFPDQPEDVTVFWGYGLFPDKEGD 394
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 415 FIKKPITECTGSEICQEWLYHMGVPQEEIVELAQSeCNTIPVYMPYVTAYFMPRAYKDRPLVVPNGSKNLAFIGNFAETE 494
Cdd:pfam06100 395 YVKKPMLECTGEEILTELLYHLGFPEDQIEEILAN-SNTIPCMMPYITAQFMPRAKGDRPEVVPEGSTNLAFIGQFVEIP 473
                         490
                  ....*....|....*....
gi 1546926085 495 RDTVFTTEYSVRTAMEAVY 513
Cdd:pfam06100 474 RDTVFTVEYSVRTAQEAVY 492
 
Name Accession Description Interval E-value
PRK13977 PRK13977
myosin-cross-reactive antigen; Provisional
1-584 0e+00

myosin-cross-reactive antigen; Provisional


Pssm-ID: 237575  Cd Length: 576  Bit Score: 1091.40  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085   1 YEAFARPKKPENVDSKSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHF 80
Cdd:PRK13977    8 YEAFARPRKPEGVDNKKAYIIGSGLASLAAAVFLIRDGQMPGENITILEELDVPGGSLDGAGNPEKGYVARGGREMENHF 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  81 ECLWDLFRSIPSLEQPDASVLDEFYWLNKEDPNYSKCRAINSGGKRIDTDgDFTLSKKAIKEILSLCMKKEEDLEDVKIS 160
Cdd:PRK13977   88 ECLWDLFRSIPSLEDPGASVLDEFYWFNKDDPNYSKARLIHKRGEILDTD-KFGLSKKDRKELLKLLLTPEEKLDDKTIE 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 161 EVFTEDFLNSNFWLYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYG 240
Cdd:PRK13977  167 DWFSPEFFETNFWYYWRTMFAFEKWHSALEMRRYMHRFIHHIGGLPDLSGLKFTKYNQYESLVLPLIKYLEDHGVDFQYG 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 241 VQVDNILVDSTSSTKIAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAPPTKALGGSWTLWKNLANQSP 320
Cdd:PRK13977  247 TKVTDIDFDITGGKKTATAIHLTRNGKEETIDLTEDDLVFVTNGSITESSTYGDMDTPAPLNRELGGSWTLWKNIAAQSP 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 321 EFGRPEKFCDHIPDKSWlVSATTTTNNKKVISYIEKLSKRDVLSGRTVTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQV 400
Cdd:PRK13977  327 EFGNPDKFCGDIPESNW-ESFTVTTKDPKILPYIERITGRDPGSGKTVTGGIVTFKDSNWLMSITVNRQPHFKNQPKNET 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 401 SVWIYALYSDVKGDFIKKPITECTGSEICQEWLYHMGVPQEEIVELAQSECNTIPVYMPYVTAYFMPRAYKDRPLVVPNG 480
Cdd:PRK13977  406 VVWGYGLYPDRPGNYVKKPMRECTGEEILQELLYHLGVPEDKIEELAADSANTIPVMMPYITSQFMPRAKGDRPLVVPEG 485
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 481 SKNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLEVDRGVPEVYASEFDARVLIDAYYQLNDRKSLPelvnnnflkrs 560
Cdd:PRK13977  486 STNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYKLNDGKLLL----------- 554
                         570       580
                  ....*....|....*....|....
gi 1546926085 561 vlKNAMKKIQGTFIEELLRKHKLL 584
Cdd:PRK13977  555 --KEGLKKIKGTYIEELLKEYGLI 576
COG4716 COG4716
Myosin-crossreactive antigen (function unknown) [Function unknown];
1-584 0e+00

Myosin-crossreactive antigen (function unknown) [Function unknown];


Pssm-ID: 443751  Cd Length: 578  Bit Score: 1087.56  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085   1 YEAFARPKKPENVDSKSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHF 80
Cdd:COG4716     8 YEAFARPRKPEGVDDKSAYLVGSGLASLAAAAFLIRDGQMPGENIHILEELDLPGGSLDGAGDPEKGYVIRGGREMENHF 87
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  81 ECLWDLFRSIPSLEQPDASVLDEFYWLNKEDPNYSKCRAINSGGKrIDTDGDFTLSKKAIKEILSLCMKKEEDLEDVKIS 160
Cdd:COG4716    88 ECLWDLFRSIPSLEDPGASVLDEFYWLNKDDPNYSKARLIHNQGE-ILDDGKFGLSKKARLEILKLFLTPEEDLDDKTIE 166
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 161 EVFTEDFLNSNFWLYWKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYG 240
Cdd:COG4716   167 DVFSEEFFESNFWLYWRTMFAFENWHSALEMKRYLHRFIHHIGGLPDLSALKFTKYNQYDSLVLPLVRWLKDHGVDFQYG 246
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 241 VQVDNILVDSTSSTKIAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAP-PTKALGGSWTLWKNLANQS 319
Cdd:COG4716   247 TKVTDVDFDISGGKKTATAIHLERDGKEETIDLTENDLVFVTNGSMTESSTYGDMDTPAPlNTDGPGGSWELWKNIAAKD 326
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 320 PEFGRPEKFCDHIPDKSWlVSATTTTNNKKVISYIEKLSKRDVLSGRTVTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQ 399
Cdd:COG4716   327 PEFGRPEKFCGNIEESNW-ESATVTTLDDKILPYIEKITGRDPYSGKVVTGGIVTFKDSNWLLSWTVNRQPHFKNQPDDV 405
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 400 VSVWIYALYSDVKGDFIKKPITECTGSEICQEWLYHMGVPqEEIVELAQSECNTIPVYMPYVTAYFMPRAYKDRPLVVPN 479
Cdd:COG4716   406 LVVWGYGLFSDKPGNYVKKPMRECTGEEILTELLYHLGVP-DQIEELAANSANTIPCMMPYITAQFMPRAAGDRPLVVPE 484
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 480 GSKNLAFIGNFAETERDTVFTTEYSVRTAMEAVYQLLEVDRGVPEVYASEFDARVLIDAYYQLNDRKSLPElvnnnflkr 559
Cdd:COG4716   485 GSVNLAFIGQFAETPRDTVFTTEYSVRTAMEAVYTLLGVDRGVPEVFPSQYDIRVLLKATYALNDGKKLPG--------- 555
                         570       580
                  ....*....|....*....|....*
gi 1546926085 560 svLKNAMKKIQGTFIEELLRKHKLL 584
Cdd:COG4716   556 --EGLLLKKLKGTYIEELLKEYKLI 578
MCRA pfam06100
MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have ...
16-513 0e+00

MCRA family; The MCRA (myosin-cross-reactive antigen) family of proteins were thought to have structural features in common with the beta chain of the class II antigens, as well as myosin, and may play an important role in the pathogenesis. More recent work shows that these proteins act as hydratase enzymes that convert linoleic acid and oleic acid to their respective 10-hydroxy derivatives. It has been suggested that MCRA proteins catalyze the first step in conjugated linoleic acid production. Proteins in this family act in an FAD dependent manner. The structure of a fatty acid double-bond hydratase from Lactobacillus acidophilus has been recently solved showing four structural domains.


Pssm-ID: 428767  Cd Length: 492  Bit Score: 899.53  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  16 KSAYLIGSGLASLAAACFLIRDGQMKGENIHILEELDISGGSLDGINMEHHGFVVRGGREMENHFECLWDLFRSIPSLEQ 95
Cdd:pfam06100   1 KKAYIVGSGIASLAAAVFLIRDAQMPGENIHILEELDVAGGSLDGAGDPEKGYVIRGGREMEFHYECLWDLLSSIPSLED 80
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  96 PDASVLDEFYWLNKEDPNYSKCRAINSGGKRIDTDGDFTLSKKAIKEILSLCMKKEEDLEDVKISEVFTEDFLNSNFWLY 175
Cdd:pfam06100  81 PGASVLDEIYWFNKRDPNYSKTRLIDNRGLEIVDDSKLGLSKKDRLELIKLFLTPEEELGDKRIEDVFSPSFFETNFWLM 160
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 176 WKTMFAFEPWHSAMEMRRYLMRFVHHIGGLADFSALKFTKYNQYESLVLPMVEYLKSHGVHFEYGVQVDNILVDSTSSTK 255
Cdd:pfam06100 161 WSTMFAFQPWHSAVEFRRYLHRFIHEIPGLNDLSGLDRTKYNQYESIILPLVKYLKDQGVDFRFNTKVTDIDFDPTGDKK 240
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 256 IAREILVNKNGKTESIPLTLDDLVFVTNGSITESSTYGDNDHPAPP-TKALGGSWTLWKNLANQSPEFGRPEKFCDHIPD 334
Cdd:pfam06100 241 TVTGIHLTQDGEEETIDLGPDDLVFVTNGSMTEGSSYGDNDTPPPLnTDELGGSWSLWKKLAAKSPDFGNPEKFCTDIPE 320
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 335 KSWlVSATTTTNNKKVISYIEKLSKRDVLsgrtvTGGIVTVADSSWQLSFTVNRQQQFKEQPKDQVSVWIYALYSDVKGD 414
Cdd:pfam06100 321 SKW-ESFTVTTKDPKFFDYIEKLTGNDPG-----TGGLVTFKDSNWLLSITVPRQPHFPDQPEDVTVFWGYGLFPDKEGD 394
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085 415 FIKKPITECTGSEICQEWLYHMGVPQEEIVELAQSeCNTIPVYMPYVTAYFMPRAYKDRPLVVPNGSKNLAFIGNFAETE 494
Cdd:pfam06100 395 YVKKPMLECTGEEILTELLYHLGFPEDQIEEILAN-SNTIPCMMPYITAQFMPRAKGDRPEVVPEGSTNLAFIGQFVEIP 473
                         490
                  ....*....|....*....
gi 1546926085 495 RDTVFTTEYSVRTAMEAVY 513
Cdd:pfam06100 474 RDTVFTVEYSVRTAQEAVY 492
NAD_binding_8 pfam13450
NAD(P)-binding Rossmann-like domain;
21-88 3.34e-03

NAD(P)-binding Rossmann-like domain;


Pssm-ID: 433218 [Multi-domain]  Cd Length: 67  Bit Score: 36.36  E-value: 3.34e-03
                          10        20        30        40        50        60        70
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 1546926085  21 IGSGLASLAAACFLirdgQMKGENIHILEELDISGGSLDGInmEHHGFVVRGG--REMENHFECLWDLFR 88
Cdd:pfam13450   2 VGAGLAGLVAAALL----AKRGFRVLVLEKRDRLGGNAYSY--RVPGYVFDYGahIFHGSDEPNVRDLLD 65
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH